Levonorgestrel intra-uterine system as a treatment option for complex endometrial hyperplasia

Zeina Haoula; Kate F. Walker; Martin C. Powell

doi:10.1016/j.ejogrb.2011.06.025

Levonorgestrel intra-uterine system as a treatment option for complex endometrial hyperplasia

Zeina Haoula, Kate F. Walker, Martin C. Powell

In: European Journal of Obstetrics & Gynecology and Reproductive Biology · 2011 · vol. 159(1) , pp. 176–179 · doi:10.1016/j.ejogrb.2011.06.025 · PMID:21741152 · W1999569870

article OA: closed CC0 ⤵ 2 in-corpus citations

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by claude@2026-06, 2026-06-13 ⓘ

This paper investigates the levonorgestrel intra-uterine system (LNG-IUS) as a treatment for complex endometrial hyperplasia.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (4)

Cited by (2)

References (25)

Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: Long-term follow-up via openalex
Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)—A systematic enquiry and overview via openalex
TISSUE CONCENTRATIONS OF LEVONORGESTREL IN WOMEN USING A LEVONORGESTREL‐RELEASING IUD via openalex
Use of the Levonorgestrel-Releasing Intrauterine System and Breast Cancer via openalex
doi:10.1136/jcp.34.6.692-d via openalex
doi:10.1016/0020-7292(89)90397-4 via openalex
doi:10.1007/978-3-642-85014-1 via openalex
doi:10.1016/j.ajog.2010.07.037 via openalex
doi:10.1097/gme.0b013e3181659837 via openalex
doi:10.1093/humrep/14.2.479 via openalex
doi:10.1016/j.ygyno.2003.07.002 via openalex
doi:10.1016/0002-9378(89)90103-8 via openalex
doi:10.1111/j.1471-0528.2002.01167.x via openalex
W2302500786 via openalex
W2338305153 via openalex
W6630777654 via openalex
W6641839808 via openalex
W6655920612 via openalex
W7073660035 via openalex
doi:10.1067/mob.2003.346 via openalex
doi:10.1093/humrep/15.suppl_3.162 via openalex
doi:10.1016/j.ejogrb.2008.02.022 via openalex
doi:10.1002/1097-0142(19850715)56:2<403::aid-cncr2820560233>3.0.co;2-x via openalex
doi:10.1016/j.ygyno.2008.06.014 via openalex
doi:10.1016/j.ygyno.2005.10.030 via openalex

Cited by (2)

Source provenance

openalex: last seen: 2026-05-11T06:42:59.773506+00:00

License: CC0 · commercial use OK

[1] TISSUE CONCENTRATIONS OF LEVONORGESTREL IN WOMEN USING A LEVONORGESTREL‐RELEASING IUD 1982

[2] Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)—A systematic enquiry and overview 2005

[3] Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: Long-term follow-up 2007

[4] Use of the Levonorgestrel-Releasing Intrauterine System and Breast Cancer 2006